Objectives To assess whether, in a cohort of patients with a small-for-gestational-age (SGA) 
INTRODUCTION
Small-for-gestational-age (SGA) fetuses with birth weight < 10 th percentile are at increased risk of perinatal death and long-term disability 1, 2 . The risk of adverse outcome is particularly marked in the subgroup with the most severe impairment of growth, reflected in birth weight < 3 rd percentile, and in those with evidence of impaired placentation and fetal oxygenation, reflected in redistribution of the fetal circulation with increased pulsatility index (PI) in the umbilical artery (UA), reduced PI in the fetal middle cerebral artery (MCA) and reduced amniotic fluid level [3] [4] [5] [6] [7] [8] . Physiological adaptation in pregnancy includes a decrease in maternal peripheral vascular resistance (PVR), expansion in plasma volume and increase in cardiac output (CO) 9 . In pregnancies with a SGA fetus, there is impairment in this physiological adaptation, which is reflected in reduced CO and increased PVR [10] [11] [12] [13] [14] [15] ; these findings are more pronounced in fetal growth restriction (FGR) than in SGA 10 . More recently the knowledge that, in pregnancies with impaired fetal growth, there is abnormal maternal cardiac function, has been utilized for screening for the risk of placental insufficiency at the routine first-trimester scan in both high-and low-risk pregnancies, and also at the routine third-trimester scan in low-risk pregnancies, with promising results 12, 16, 17 . The aim of this study was to assess whether maternal hemodynamics, fetal biometry and Doppler indices at presentation, in women referred to a specialist clinic for the management of pregnancy with a SGA fetus, identified by routine ultrasound screening in the second and/or third trimester(s), can predict the subsequent development of an abnormal fetal Doppler index or birth weight < 3 rd percentile.
METHODS

Patient selection
This was a prospective observational cohort study conducted at a specialist clinic for the management of pregnancies with a SGA fetus at King's College Hospital, London, UK. The routine practice in this hospital is to offer three ultrasound examinations during pregnancy: a scan at 11-13 weeks' gestation for dating and estimation of the risk for fetal trisomies; an anomaly scan at 19-24 weeks; and a third-trimester growth scan at 35-37 weeks. Additional scans for assessment of fetal growth are carried out for suspicion of SGA based on symphysiofundal height measurement, serum pregnancy-associated plasma protein-A ≤ 0.2 multiples of the median at 11-13 weeks, uterine artery (UtA)-PI ≥ 1.6 at 19-24 weeks, single umbilical artery, medical conditions associated with FGR (such as lupus erythematosus, chronic hypertension, asthma, diabetes) or history of FGR or pre-eclampsia.
When estimated fetal weight (EFW) on sonographic fetal biometry is ≤ 10 th percentile, patients are referred to a specialist clinic. This study reports on the maternal hemodynamic characteristics and their association with fetal biometry and Doppler indices in 86 patients referred to the SGA clinic between April 2016 and October 2016. Women were grouped according to whether they had an abnormal fetal Doppler index at presentation (Group 1), subsequently developed an abnormal fetal Doppler index (Group 2) or did not develop an abnormal fetal Doppler index throughout pregnancy (Group 3). Gestational age was determined from fetal crown-rump length at 11-13 weeks (81 patients) or fetal head circumference at 19-24 weeks (five patients: two in Group 1, one in Group 2 and two in Group 3) 18, 19 . Pregnancies with chromosomal abnormality or congenital infection were excluded.
Maternal demographics were recorded at the booking appointment and updated at subsequent growth scans. Demographics recorded were age, height, weight, ethnicity (white, black, South-East Asian, other), cigarette smoking (yes or no), medication (labetalol, nifedipine, methyldopa, steroids, betamimetics), medical history (asthma, chronic hypertension, diabetes) and body surface area (BSA) at first presentation at the SGA clinic.
Maternal hemodynamic and fetal assessment
Maternal hemodynamic assessment was performed on initial presentation to the SGA clinic using a non-invasive bioreactance method (NICOM; Cheetah Medical Ltd, Maidenhead, Berkshire, UK) 20 . This cardiac output monitor has been validated in pregnant and postpartum women by comparing it against transthoracic echocardiography, with good correlation in the third trimester of pregnancy 21 . Four dual surface electrodes were placed on the posterior aspect of the thorax and, after 15 min of rest in an upright sitting position (to remove the impact of aortocaval compression on maternal cardiac output), recordings were made over 5 min at 1-min intervals. The average value of the five cycles was used for the estimation of each cardiac parameter. Cardiac parameters recorded were CO (L/min), stroke volume (SV) (mL), heart rate (HR) (bpm) and PVR (dynes × s/cm 5 ). SV was calculated based on the relative phase shift of the electrical current between the input and output signals transmitted by the electrodes; CO is the product of SV and HR. Mean arterial pressure (MAP) was defined as 2 × (diastolic blood pressure + systolic blood pressure)/3, and PVR was calculated using the equation PVR = (80 × MAP)/CO. Blood-pressure recordings were taken concurrently with maternal hemodynamic assessment, in accordance with British Hypertension Society guidance 22 . In a SGA clinic in which patients are referred at different points in pregnancy (from 20 to 42 weeks' gestation), it is impossible to recruit a control group in order to match all referred patients. Previously established reference ranges across gestation for maternal hemodynamic 23 and fetal variables 19, 24, 25 were therefore used and their Z-scores calculated, controlling for the effect of gestational age on the examined parameters. EFW percentile and Z-score were derived from sonographic measurements of fetal head circumference (HC), abdominal circumference (AC) and femur length (FL) 19, 26 , and birth-weight percentile according to the method of Maršál et al. 27 . Doppler assessment included the measurement of UA-PI, fetal MCA-PI and mean UtA-PI. Measurement of the deepest vertical pool (DVP) was used to assess amniotic fluid volume.
Definitions and pregnancy management
Abnormal fetal Doppler was defined as UA-PI >95 th percentile and/or MCA-PI <5 th percentile 7 . The consensus definition of FGR, developed through a Delphi procedure, was used to define FGR at subsequent visits 28 . Follow-up ultrasound assessment was carried out every 1-2 weeks, and timing of delivery was based on national guidelines and evidence from randomized controlled trials 7, 29, 30 . More specifically, in FGR before 32 weeks with absent or reversed end-diastolic flow (EDF) in the UA, delivery was recommended at 32 weeks or sooner if there were abnormal ductus venosus Doppler indices or pathological computerized cardiotocography 29, 30 . For FGR with abnormal UA-PI after 32 weeks, delivery was planned at 37 weeks if UA-PI was >95 th percentile but there was positive EDF, or sooner if EDF was absent or reversed 7 . Fetuses with EFW < 10 th percentile but with normal Doppler indices and amniotic fluid were offered delivery at term 7 . Pregnancy outcomes were obtained from local hospital records or from the patient directly if they delivered at a hospital other than King's College Hospital.
Ethical approval for the study was obtained by the Hospital Ethics committee (REC reference:15/LO/1815), and written consent was obtained from all recruited patients.
Statistical analysis
Due to the spread of gestational age at presentation, we calculated Z-scores for all examined variables. More specifically, Z-scores for maternal hemodynamic variables controlled for gestational age and maternal demographic characteristics (age, height, weight, BSA, ethnicity, parity, previous pre-eclampsia, smoking) 23 , and those for fetal biometry and Doppler variables controlled for gestational age 19, 24, 25 . Maternal demographics, fetal biometry, UA-PI, MCA-PI, mean UtA-PI, amniotic fluid DVP and maternal hemodynamic variables were compared between women with an abnormal fetal Doppler index at presentation (Group 1), those who had developed an abnormal fetal Doppler index at a subsequent visit (Group 2) and those who did not develop an abnormal fetal Doppler index throughout pregnancy (Group 3). Comparisons were also made between the above parameters in women who delivered a neonate with a birth weight < 3 rd percentile and those who delivered a neonate with a birth weight ≥ 3 rd percentile. The Kolmogorov-Smirnov test was used to assess the normality of the distribution of the data. For the comparison of Groups 1, 2 and 3, ANOVA and the Kruskal-Wallis test were used for normally and non-normally distributed data, respectively, with the Bonferroni correction for the post-hoc tests. For comparison of pregnancies with birth weight ≥ 3 rd percentile and those with birth weight < 3 rd percentile, the unpaired t-test and Mann-Whitney U-test were used for normally and non-normally distributed data, respectively. Categorical variables were compared using the chi-square or Fisher's exact test, as appropriate.
Bivariate correlation was used to assess the relationship between maternal hemodynamic and fetal biometry and Doppler variables, and the correlation coefficients were tabulated with corresponding significance levels. Multivariate logistic regression analysis was performed to assess the additional contribution of maternal hemodynamic variables (Z-scores of SV, HR, MAP) to the prediction of birth weight < 3 rd percentile, compared with using solely maternal demographics (as described above), fetal biometry (Z-scores of HC, AC and FL), fetal and placental Doppler indices (Z-scores of UA-PI, MCA-PI and UtA-PI) and gestational age at presentation.
The statistical software package SPSS (Version 22; SPSS Inc., Chicago, IL, USA) and MedCalc Statistical Software version 17.9.7 (MedCalc Software bvba, Ostend, Belgium; http://www.medcalc.org; 2017) were used for data analysis.
RESULTS
Comparison between groups at presentation
The maternal demographic and hemodynamic characteristics and pregnancy outcomes of the total study population (n = 86) and according to group are presented in Table 1 and Figure 1 . There were no significant differences in maternal demographics between groups, apart from a higher rate of women taking labetalol and methyldopa for blood-pressure control in Group 1 vs Group 3. Gestational age at presentation to the SGA clinic was similar in all groups (around 32 weeks), but there was a significant difference in EFW percentile at presentation between Groups 1 and 3 ( Table 1 ). All three groups had a low negative Z-score for maternal CO (owing to a lower SV) and a high positive Z-score for PVR. CO and SV Z-scores were lower in Group 1 than in Groups 2 and 3, but the difference did not reach statistical significance. Group 1 had higher MAP Z-score than did Group 2, and higher PVR Z-score than did Groups 2 and 3.
All three groups had low negative Z-scores of logHC, logAC and FL. Group 1 had lower logHC Z-score than did Group 2 and lower logAC Z-score than did both Groups 2 and 3. There were no differences in FL Z-scores between the groups. All three groups had a high positive Z-score for UA-PI, with a gradual reduction from Group 1 to Group 3; Group 3 had a lower UA-PI Z-score compared with both Groups 1 and 2. There was a gradual decline in MCA-PI Z-score from Group 3 to Group 1, with Group 3 having significantly higher MCA-PI Z-score compared with Group 1. Group 1 had a higher prevalence of DVP < 5 th percentile compared with Group 3. Mean UtA-PI Z-score was higher in Group 1 Data are given as mean ± SD, median (interquartile range) or n (%). ¶Overall P-value of ANOVA or Kruskal-Wallis test for comparison between three study groups. Statistically significant difference between: Groups 1 and 2: *P < 0.05; **P < 0.01; Groups 1 and 3: †P < 0.05; † †P < 0.01; † † †P < 0.0001; and Groups 2 and 3: §P < 0.05; § §P < 0.01; § § §P < 0.0001. AC, abdominal circumference; CS, Cesarean section; DVP, deepest vertical pool; GA, gestational age; HC, head circumference; NICU, neonatal intensive care unit; PIH, pregnancyinduced hypertension; PVR, peripheral vascular resistance; UtA, uterine artery.
than in Groups 2 and 3, but the difference did not reach statistical significance. Birth weight was < 3 rd centile in 10 (71%) babies in Group 1, 11 (58%) in Group 2 and 18 (34%) in Group 3.
In Group 1, four (29%) patients were treated with three different combinations of three antihypertensive medications, as follows: two took labetalol only, which was commenced in the third trimester; one took methyldopa only, which was commenced in the second trimester; and one patient was on a combination of three antihypertensives (methyldopa commenced in the second trimester and nifedipine and labetalol, both commenced in the third trimester). In Group 2, no patient received antihypertensive medication. In Group 3, three (5.7%) patients were treated with three different combinations of two antihypertensive medications, as follows: one was commenced on labetalol in the second trimester; one was commenced on nifedipine in the third trimester; and one was on a combination of labetalol and nifedipine, with treatment started in the second and third trimesters, respectively.
Correlation between maternal hemodynamics, fetal biometry and fetal and placental Doppler indices
There were modest correlations between maternal hemodynamic, fetal biometry and fetal and placental Doppler variable Z-scores ( Table 2 ). The Z-score of CO was correlated positively with that of MCA-PI and negatively with that of UtA-PI. The Z-score of HR was correlated positively with those of logAC and logFL and negatively with that of UtA-PI. The Z-scores of MAP and logPVR were correlated positively with that of UA-PI and negatively with those of logHC, logAC and MCA-PI.
Comparison between pregnancies with birth weight < 3 rd percentile and those with birth weight ≥ 3 rd percentile Of the total study population, 39 patients (45.3%) delivered a neonate with a birth weight < 3 rd percentile and 47 (54.7%) patients delivered a neonate with a birth weight ≥ 3 rd percentile (Table S1 ). There was no significant difference in maternal demographics between these groups. Women who had babies with a birth weight < 3 rd percentile, compared with those with birth weight ≥ 3 rd percentile, had lower EFW centile at presentation, delivered on average 1 week earlier, had lower Z-scores of maternal CO, SV, HR, logAC and FL, and higher Z-scores of logPVR and UtA-PI.
Multivariate logistic regression analysis for the prediction of delivery of a neonate with a birth weight < 3 rd percentile (Table S2 and Figure S1 ) demonstrated that the addition of maternal hemodynamic variables produced a better prediction model than did the one based solely on maternal demographics, fetal biometry and Doppler indices (difference between areas under receiver-operating characteristics curves, 0.18 (95% CI, 0.06-0.29); P = 0.002). On the other hand, on multivariate logistic regression analysis for the prediction of subsequent FGR, maternal hemodynamic variables did not provide an improvement in the prediction model based on maternal demographics, fetal biometry and Doppler indices (logitFGR = 4.6 − (1.2 × logHC Z-score) − (2.5 × UA-PI Z-score); P < 0.0001, R 2 Nagelkerke = 0.32).
DISCUSSION
Principal findings
The findings of this study demonstrate that pregnancies referred to a SGA clinic with EFW ≤ 10 th percentile will comprise three groups: those with an abnormal fetal Doppler index at presentation (Group 1); those that have developed an abnormal fetal Doppler index at a subsequent visit (Group 2); and those that do not develop Consequently, the prediction model to screen for subsequent development of an abnormal fetal Doppler index was poor and without any contribution from maternal hemodynamics. On the other hand, pregnancies with a birth weight < 3 rd percentile had distinct differences compared with those with birth weight ≥ 3 rd percentile in terms of maternal hemodynamics and fetal Doppler indices. Consequently, there was a significant improvement in the prediction of delivery with birth weight ≤ 3 rd percentile by maternal demographics and fetal biometry and Doppler indices with the addition of maternal hemodynamics.
The correlations between maternal hemodynamic, fetal biometry and fetal and placental Doppler variables were statistically significant but of modest power. The fact that higher CO Z-score was associated with higher MCA-PI Z-score and lower UtA-PI Z-score, while higher MAP and PVR Z-scores were associated with higher UA-PI Z-score and lower MCA-PI, HC and AC Z-scores reflects that volume depletion and high resistance in the maternal cardiovascular system are associated with increased placental resistance and fetal growth impairment. However, the correlations are modest and explain only a small part of the variability in fetal biometry and Doppler variables.
The fact that 28% of women in Group 1 were on antihypertensive medication could partly explain the low CO Z-score seen in this group. However, none of the women in Group 2, whose fetus subsequently developed an abnormal Doppler index, was on antihypertensive treatment and, therefore, their impaired hemodynamic profile cannot be attributed to maternal medication.
Comparison with previous studies and clinical implications
Our work is in agreement with studies in both high-and low-risk populations that portrayed in pregnancies with SGA or FGR fetuses impaired maternal cardiovascular adaptation with reduced CO and increased PVR [10] [11] [12] [13] [14] [15] [16] 23 . Furthermore, lower SV and CO Z-scores and higher PVR Z-score in Group 1 than in Group 3 is in agreement with the findings of two echocardiography studies comparing maternal hemodynamic function between FGR and SGA pregnancies in the third trimester 10, 14 . What was unexpected in the current study was that maternal hemodynamics, fetal biometry and Doppler indices were similar between Groups 2 and 3, despite the fact that abnormal fetal Doppler indices were evident in Group 2 and led to their giving birth within 5 weeks from presentation. This finding raises two questions. The first is whether Group 2 was at an earlier stage of the FGR process and would eventually also transition to an even more volume-depleted and vasoconstricted state, similar to Group 1, or whether they had a more favorable maternal hemodynamic profile, and further insult, such as hypertension with subsequent antihypertensive treatment, worsened maternal and fetal homeostasis. The latter does not appear to be the case, as none of the pregnancies in Group 2 was complicated by a hypertensive disorder and they did not have a higher prevalence of a pre-existing medical condition.
The second question, concerning Group 3, is why both the maternal hemodynamic and fetal biometry and Doppler variables were abnormal in a similar pattern to those seen in Group 2. One possible explanation for the impaired maternal hemodynamic profile of Group 3 could be the fact that in this group 34% of babies had a birth weight < 3 rd percentile, albeit with normal fetal Doppler indices. However, one would have expected Group 3, which did not exhibit Doppler deterioration in the subsequent few weeks and had a rate of emergency Cesarean section 3.6 times lower than that of Group 2, to have at presentation a better maternal hemodynamic profile. This is a potentially concerning finding and warrants further investigation with regard to whether mothers with a SGA pregnancy and normal fetal Doppler indices have significantly impaired cardiovascular adaptation, similar to those who subsequently develop an abnormal fetal Doppler index. These concerns are in keeping with findings from studies that demonstrated in SGA babies antenatal fetal brain magnetic resonance imaging findings suggestive of brain reorganization 31 , abnormal cardiovascular programming at 5 years of age 32 , worse educational performance at 12 and 18 years of age 33 and higher risk of insulin resistance and metabolic syndrome in later life 34 . Further work is needed in this area, as traditional policies of planning later delivery for SGA vs FGR fetuses at term may not be entirely justified if it exposes them to longer periods of relative hypoxia and worse outcome in adult life 35 . There is evidence that birth weight < 3 rd percentile is an antepartum predictor of adverse outcome, independent of Doppler evidence of FGR 36 . Neonates with a birth weight < 3 rd percentile, compared with appropriate-for-gestational-age pregnancies, carry an 11-fold, 17-fold and 4-fold increased risk of stillbirth, neonatal hypoglycemia and neonatal death, respectively 4, 5 . Their risk of neonatal encephalopathy is increased 38-fold and the development of cerebral palsy, even in the absence of neonatal encephalopathy, is increased 2.8-fold 3, 6 . Therefore, birth weight < 3 rd percentile should be considered as a target in its own right for any screening program aiming at reducing perinatal mortality and morbidity resulting from FGR. It is a positive finding, therefore, that the addition of maternal hemodynamic function added significantly to the power of a model based on fetal biometry and Doppler indices and maternal demographic variables for the prediction of birth weight < 3 rd percentile. More work could assess whether earlier delivery in pregnancies with a combination of impaired maternal cardiovascular adaptation and evidence of placental insufficiency would lead to improved outcome in such a high-risk group.
Strengths and limitations
The strength of this study is that it allowed concomitant comparison of maternal cardiac function, as well as fetal biometry, fetal and placental Doppler studies and amniotic fluid volume, between pregnancies with a common referral criterion to a dedicated SGA clinic but with distinct outcomes in terms of ensuing FGR and timing of its development.
A limitation of the study is that, owing to the nature of a SGA referral clinic, the entry point in the study could not be standardized, as it followed the needs of everyday practice. However, using reference ranges from pregnancies with a normal outcome, we controlled for changes with gestational age and, in terms of hemodynamic variables, for maternal ethnicity and somatometric parameters, providing Z-scores for all variables. Furthermore, this was a cross-sectional study, therefore it was not possible to determine whether there was an increase or fall in hemodynamic parameters preceding the time of assessment at the SGA clinic. This, together with the relatively small sample size, indicates the need for larger longitudinal studies to ascertain longitudinal hemodynamic changes in these pregnancies.
Conclusions
Pregnant women with EFW ≤ 10 th percentile referred to a dedicated SGA clinic have reduced maternal SV and CO with increased PVR. Prediction of birth weight < 3 rd percentile at first visit, but not of subsequent Doppler deterioration, is improved by the assessment of maternal hemodynamic function along with maternal history and demographics, fetal biometry, Doppler indices and amniotic fluid volume.
SUPPORTING INFORMATION ON THE INTERNET
The following supporting information may be found in the online version of this article:
Table S1
Maternal demographic and hemodynamic characteristics at presentation and pregnancy outcome in pregnancies with fetus with estimated fetal weight ≤ 10 th percentile, according to birth weight Figure S1 Receiver-operating characteristics curves for prediction of delivery of neonate with birth weight < 3 rd percentile in 86 pregnancies with estimated fetal weight ≤ 10 th percentile at referral, according to whether maternal hemodynamic parameters were incorporated into the prediction model. This article has been selected for Journal Club. Hemodinámica materna, biometría fetal eíndices Doppler en embarazos controlados por sospecha de restricción del crecimiento fetal RESUMEN Objetivo Evaluar si, en una cohorte de pacientes con un feto pequeño para la edad gestacional (PEG) con un peso fetal estimado por debajo del percentil 10 o , la hemodinámica materna, la biometría fetal y losíndices Doppler en el momento de la presentación pueden predecir el desarrollo posterior de uníndice Doppler fetal anormal o el nacimiento de un bebé con peso al nacer por debajo del percentil 3 o .
Métodos Este fue un estudio de observación prospectivo de cohorte realizado en una clínica especializada en la atención a embarazos con un feto PEG en el hospital King's College de Londres, en el Reino Unido. La población del estudio incluyó 86 embarazos con fetoúnico PEG, presentados a una edad gestacional con una mediana de 32 (rango: 26-35) semanas. Se midió la función cardíaca materna mediante un monitor de biorreactividad transtorácica no invasivo, así como la presión arterial media, la biometría fetal y losíndices de pulsatilidad (IP) de la arteria umbilical (AUm), la arteria cerebral media (ACM) y la arteria uterina (AUt) del feto, y la columna máxima de líquido amniótico. Los valores Z de estas variables se calcularon a partir de rangos de referencia reportados y se compararon los valores entre embarazos con evidencia de uníndice Doppler fetal anómalo en el momento de la presentación (Grupo 1), aquellos que habían desarrollado uníndice Doppler anómalo en una visita posterior (Grupo 2) y aquellos que no desarrollaron uníndice Doppler anómalo durante el embarazo (Grupo 3). El Doppler fetal anómalo se definió como IP-AUm > percentil 95 o y/o IP-ACM < percentil 5 o . También se compararon las diferencias en las variables medidas en el momento de la presentación entre los embarazos que resultaron en un neonato con peso al nacer <3
er percentil y los que resultaron con un neonato con peso al nacer ≥3 er percentil. Se empleó un análisis de regresión logística multivariante para determinar los predictores significativos del peso al nacer <3 er percentil y la evolución del Doppler fetal de normal a anómalo.
Resultados En la población del estudio, 14 (16%) casos pertenecían al Grupo 1, 19 (22%) al Grupo 2 y 53 (62%) al Grupo 3. El peso al nacer fue <3 er percentil en 39 (45%) casos y ≥3 er percentil en 47 (55%). Se observó una disminución del gasto cardíaco y del volumen sistólico y un aumento de la resistencia vascular periférica en comparación con una población normal, y las desviaciones de lo normal fueron más marcadas en el Grupo 1. Los embarazos con peso al nacer <3 er percentil, en comparación con aquellos con peso al nacer ≥3 er percentil, presentaron mayores desviaciones de lo normal en la biometría fetal, el gasto cardíaco materno, el volumen sistólico, la frecuencia cardíaca, la resistencia vascular periférica y el IP de la AUt. El análisis de regresión logística multivariante demostró que, en la predicción del peso al nacer <3 er percentil, el perfil hemodinámico materno proporcionó una mejoría significativa en la predicción que ofrecía la demografía materna, la biometría fetal, el IP-AUt, el IP-AUm y el IP-ACM (diferencia entre lasáreas bajo las curvas de las características operativas del receptor de 0,18 (IC 95%: 0,06-0,29) P=0,002). En contraste, no hubo una contribución independiente significativa de la hemodinámica materna a la predicción del desarrollo posterior de Doppler fetal anómalo.
